EUVIMEDEUVIMED entdecken
Open Access

Provision of Digital Health Technologies for Opioid Use Disorder Treatment by US Health Care Organizations

Chris Miller-Rosales, Nancy E Morden, Mary F Brunette, Susan H Busch, John B Torous, Ellen R Meara

JAMA Network Open · 17.07.2023 · 6 (7) · e2323741

DOI: 10.1001/jamanetworkopen.2023.23741 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 17.07.2023. Verfasst von Chris Miller-Rosales und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts. Hauptthemen laut MEDLINE: Opioid-Related Disorders, Accountable Care Organizations. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, NIMH NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Digital health technologies may expand organizational capacity to treat opioid use disorder (OUD). However, it remains unclear whether these technologies serve as substitutes for or complements to traditional substance use disorder (SUD) treatment resources in health care organizations.

Objective

To characterize the use of patient-facing digital health technologies for OUD by US organizations with accountable care organization (ACO) contracts. Design, Setting, and Participants This cross-sectional study analyzed responses to the 2022 National Survey of Accountable Care Organizations (NSACO), collected between October 1, 2021, and June 30, 2022, from US organizations with Medicare and Medicaid ACO contracts. Data analysis was performed between December 15, 2022, and January 6, 2023. Exposures Treatment resources for SUD (eg, an addiction medicine specialist, sufficient staff to treat SUD, medications for OUD, a specialty SUD treatment facility, a registry to identify patients with OUD, or a registry to track mental health for patients with OUD) and organizational characteristics (eg, organization type, Medicaid ACO contract). Main Outcomes and Measures The main outcomes included survey-reported use of 3 categories of digital health technologies for OUD: remote mental health therapy and tracking, virtual peer recovery support programs, and digital recovery support for adjuvant cognitive behavior therapy (CBT). Statistical analysis was conducted using descriptive statistics and multivariable logistic regression models.

Results

Overall, 276 of 505 organizations responded to the NSACO (54.7% response rate), with a total of 304 respondents. Of these, 161 (53.1%) were from a hospital or health system, 74 (24.2%) were from a physician- or medical group–led organization, and 23 (7.8%) were from a safety-net organization. One-third of respondents (101 [33.5%]) reported that their organization used at least 1 of the 3 digital health technology categories, including remote mental health therapy and tracking (80 [26.5%]), virtual peer recovery support programs (46 [15.1%]), and digital recovery support for adjuvant CBT (27 [9.0%]). In an adjusted analysis, organizations with an addiction medicine specialist (average marginal effect [SE], 32.3 [4.7] percentage points; P < .001) or a registry to track mental health (average marginal effect [SE], 27.2 [3.8] percentage points; P < .001) were more likely to use at least 1 category of technology compared with otherwise similar organizations lacking these capabilities. Conclusions and Relevance In this cross-sectional study of 276 organizations with ACO contracts, organizations used patient-facing digital health technologies for OUD as complements to available SUD treatment capabilities rather than as substitutes for unavailable resources. Future studies should examine implementation facilitators to realize the potential of emerging technologies to support organizations facing health care practitioner shortages and other barriers to OUD treatment delivery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Opioid-Related DisordersAccountable Care OrganizationsAgedHumansUnited StatesCross-Sectional StudiesMedicareMedicaid

Autor:innen und Institutionen

  • Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts.
  • Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine, Lebanon, New Hampshire.
  • UnitedHealthcare, Minnetonka, Minnesota.
  • Department of Psychiatry, Geisel School of Medicine, Dartmouth College, Hanover, New Hampshire.
  • Bureau of Mental Health Services, New Hampshire Department of Health and Human Services, Concord.
  • Department of Health Policy and Management, Yale School of Public Health, New Haven, Connecticut.

Förderung

  • NIDA NIH HHS
  • NIMH NIH HHS

Zitieren

APA

Miller-Rosales, C., Morden, N. E., Brunette, M. F., Busch, S. H., Torous, J. B., & Meara, E. R. (2023). Provision of Digital Health Technologies for Opioid Use Disorder Treatment by US Health Care Organizations. JAMA Network Open, 6(7), e2323741. https://doi.org/10.1001/jamanetworkopen.2023.23741

Vancouver

Miller-Rosales C, Morden NE, Brunette MF, Busch SH, Torous JB, Meara ER. Provision of Digital Health Technologies for Opioid Use Disorder Treatment by US Health Care Organizations. JAMA Network Open. 2023;6(7):e2323741. doi:10.1001/jamanetworkopen.2023.23741

BibTeX
@article{MillerRosales2023,
  author = {Miller-Rosales, Chris and Morden, Nancy E and Brunette, Mary F and Busch, Susan H and Torous, John B and Meara, Ellen R},
  title = {Provision of Digital Health Technologies for Opioid Use Disorder Treatment by US Health Care Organizations},
  journal = {JAMA Network Open},
  year = {2023},
  volume = {6},
  number = {7},
  pages = {e2323741},
  doi = {10.1001/jamanetworkopen.2023.23741}
}
Kostenlos starten →